EXEL
Exelixis, Inc. · Healthcare
EVP, Research and Development Dana Aftab sold $2.2M of Exelixis, Inc.
Sold$2,187,758
$50.35Price
43,451Shares
−7%Stake
What EXEL did after the filing
- The stock from Fri, May 29 open, $51.41
- +2.5%
- S&P 500, same days
- −2.4%
5 of 30 trading days so far, to the Jun 5 close.
Traded Tue, May 26. Filed Thu, May 28, 6:25 PM ET, after the close. Returns use the May 29 open and the Jun 5 close. Not investment advice.